The article explores the controversial backgrounds of staff at Elon Musk's Department of Government Efficiency, particularly focusing on Alexandra Beynon, a former head of engineering at a ketamine therapy startup called Mindbloom. As Mindbloom aims to provide at-home ketamine treatment for mental health, questions arise about the oversight and safety of such therapies, especially after a report indicating significant misuse of at-home ketamine. The article underscores the need for proper therapeutic guidance in this burgeoning industry, noting that some patients may struggle without adequate support during treatment.
In 2023, a study found that 55% of respondents misused at-home ketamine treatments, underscoring concerns about the safety and regulation in the psychedelic therapy space.
Mindbloom's cofounder noted that 35% of applicants are denied treatment, typically due to substance abuse issues, highlighting the need for careful patient selection.
Collection
[
|
...
]